Show simple item record

dc.contributor.authorJ Gordon Millichap
dc.contributor.otherNorthwestern University Feinberg School of Medicine
dc.date.accessioned2016-03-14T05:00:21Z
dc.date.available2025-10-02T04:17:48Z
dc.date.issued01-05-2003
dc.identifier.issn-
dc.identifier.urihttps://www.pediatricneurologybriefs.com/articles/1511
dc.description.abstractThe safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy and group 2) with EEG abnormalities without seizures, were determined in a study of 119 children (98 males, 21 females; ages 6 to 16 years) at Gazi University, Ankara, Turkey.
dc.format-
dc.language.isoEN
dc.publisherPediatric Neurology Briefs Publishers
dc.relation.uri['https://www.sciencedirect.com/journal/china-journal-of-accounting-research/publish/guide-for-authors', 'https://www.sciencedirect.com/journal/china-journal-of-accounting-research', 'https://www.elsevier.com/authors/open-access/choice#waivers']
dc.rights['CC BY', 'CC BY-NC-ND']
dc.subject['accounting', 'finance', 'auditing', 'corporate governance in china', 'china circle', 'emerging markets', 'Accounting. Bookkeeping', 'HF5601-5689']
dc.subject.lccPediatrics
dc.titleEffect of Methylphenidate in ADHD with Epilepsy or with EEG Abnormalities without Seizures
dc.typeArticle
dc.description.keywordsmethylphenidate
dc.description.keywordsantiepileptic
dc.description.keywordssleep disorder
dc.description.pages35-36
dc.description.doi10.15844/pedneurbriefs-17-5-3
dc.title.journalPediatric Neurology Briefs
dc.identifier.e-issn2166-6482
dc.identifier.oaioai:doaj.org/journal:b1973464eb3e491ab75375149a5cf556
dc.journal.infoVolume 17, Issue 5


This item appears in the following Collection(s)

Show simple item record